Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis

Autor: Miranda P. Steenbeek, Majke H.D. van Bommel, Johan Bulten, Julia A. Hulsmann, Joep Bogaerts, Christine Garcia, Han T. Cun, Karen H. Lu, Heleen J. van Beekhuizen, Lucas Minig, Katja N. Gaarenstroom, Marielle Nobbenhuis, Mateja Krajc, Vilius Rudaitis, Barbara M. Norquist, Elizabeth M. Swisher, Marian J.E. Mourits, Leon F.A.G. Massuger, Nicoline Hoogerbrugge, Rosella P.M.G. Hermens, Joanna IntHout, Joanne A. de Hullu

Publikováno v: J Clin Oncol
Journal of Clinical Oncology, 40(17), 1879-1891. American Society of Clinical Oncology
Journal of Clinical Oncology, 40(17), 1879-+. LIPPINCOTT WILLIAMS & WILKINS
Journal of Clinical Oncology, 40, 17, pp. 1879-1891
Journal of Clinical Oncology, 40(17), 1879-1891. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 40, 1879-1891

PURPOSE After risk-reducing salpingo-oophorectomy (RRSO), BRCA1/ 2 pathogenic variant (PV) carriers have a residual risk to develop peritoneal carcinomatosis (PC). The etiology of PC is not yet clarified, but may be related to serous tubal intraepith

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1353d6db4e49aa6c2b881b6b19020cf8
https://doi.org/10.1200/JCO.21.02016